Related Experiment Video
Updated: Apr 19, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway
Hangjie Ying1, Yanhua Kang1, Hang Zhang1
1Department of Basic Medical Science, Key Laboratory of Immunology and Molecular Medicine, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 310036, China;
Abstract:
A polarized macrophage response is presumed to have a pivotal role in a variety of immunological pathophysiology. However, the molecular mechanism underlying macrophage functional shaping remains largely unknown. In this study, we reveal a pivotal role of miR-127 in macrophage development and thereby the pathogenesis of inflammation and lung injury. In particular, miR-127 was demonstrated to be prominently induced upon TLR engagement and repressed by the M2-prone cytokines. Enforced expression of miR-127 in macrophages resulted in significantly increased production of proinflammatory cytokines, whereas deletion of miR-127 impaired M1 gene expression and led to a M2-biased response. Accordingly, intratracheal administration of miR-127 resulted in an exaggerated pulmonary inflammation and injury. Conversely, antagonizing of miR-127 suppressed production of the proinflammatory cytokines and rendered the mice more refractory to the inflammation-associated pathology. Mechanistically, miR-127 demonstrated to target B cell lymphoma 6 (Bcl6) and remarkably downregulated its expression and subsequently dual specificity phosphatase 1 (Dusp1), which in turn enhanced the activation of JNK kinase and hence the development of proinflammatory macrophages. Thereby, reconstitution with the expression of Bcl6 or Dusp1 or inhibition of JNK activity impaired miR-127-mediated skewing of M1 proinflammatory macrophages, whereas interference of Bcl6 or Dusp1 expression abrogated the anti-inflammatory property of anti-miR-127. Together, these data establish miR-127 as a molecular switch during macrophage development and as a potential target for treatment of inflammatory diseases.
Insights
MicroRNA-127 (miR-127) drives inflammation and lung injury by promoting proinflammatory macrophages. Inhibiting miR-127 reduces inflammation, suggesting it as a therapeutic target for inflammatory diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Macrophage polarization is crucial in immunological diseases, but the mechanisms controlling their function are unclear.
- Understanding macrophage functional shaping is key to addressing inflammatory pathologies.
Purpose of the Study:
- To elucidate the role of microRNA-127 (miR-127) in macrophage development and its impact on inflammation and lung injury.
- To identify miR-127 as a potential therapeutic target for inflammatory conditions.
Main Methods:
- Investigated miR-127 induction upon Toll-like receptor (TLR) engagement and repression by M2-prone cytokines.
- Utilized enforced expression and deletion of miR-127 in macrophages.
- Administered miR-127 intratracheally in a mouse model.
- Performed mechanistic studies involving B cell lymphoma 6 (Bcl6), dual specificity phosphatase 1 (Dusp1), and JNK kinase signaling.
Main Results:
- miR-127 is induced by TLRs and repressed by M2 cytokines, promoting proinflammatory cytokine production.
- miR-127 deletion leads to M2-biased responses and impaired M1 gene expression.
- Intratracheal miR-127 exacerbates pulmonary inflammation and injury; its antagonism confers protection.
- Mechanistically, miR-127 targets Bcl6, downregulating Dusp1 and activating JNK, promoting M1 macrophage development.
Conclusions:
- miR-127 acts as a molecular switch in macrophage development, driving M1 polarization and inflammatory responses.
- Targeting miR-127 offers a potential therapeutic strategy for treating inflammatory diseases like lung injury.
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
TGF - β Signaling Pathway